Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole for the Augmentation of Antidepressant Therapy: An Observational, Outpatients Study in Inadequate Responders Diagnosed With Major Depressive Disorder

NCT01429831 is registered in ClinicalTrials.gov with Taiwan Otsuka Pharm. Co., Ltd as lead sponsor.

NCT NCT01429831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01429831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole for the Augmentation of Antidepressant Therapy: An Observational, Outpatients Study in Inadequate Responders Diagnosed With Major Depressive Disorder
Lead sponsor
Taiwan Otsuka Pharm. Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
May 31, 2013
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder